CBOA
WX

Commonwealth Bank of Australia’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Commonwealth Bank of Australia’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-761,636
Closed -$32.9M – 865
2015
Q3 		$32.9M Sell
761,636
-1,644,280
-68% -$69.4M 0.42% 58
2015
Q2 		$102M Sell
2,405,916
-220,076
-8% -$9.28M 1.35% 21
2015
Q1 		$102M Hold
2,625,992
– – 1.38% 20
2014
Q4 		$88.4M Sell
2,625,992
-757
-0% -$26.7K 1.25% 18
2014
Q3 		$92M Hold
2,626,749
– – 1.19% 20
2014
Q2 		$86.3M Sell
2,626,749
-225,431
-8% -$7.71M 1.16% 21
2014
Q1 		$105M Sell
2,852,180
-437,515
-13% -$16.1M 0.67% 30
2013
Q4 		$126M Sell
3,289,695
-2,742
-0.1% -$86.6K 0.87% 16
2013
Q3 		$90.2M Buy
3,292,437
+10,604
+0.3% +$251K 0.65% 29
2013
Q2 		$68.9M Buy
+3,281,833
New +$64.1M 0.52% 40

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Commonwealth Bank of Australia's WX Position: Q4 2015 in Review

Commonwealth Bank of Australia sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 761,636 shares — an estimated $32.9M sold.

Commonwealth Bank of Australia first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $126M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Commonwealth Bank of Australia reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 761,636 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $32.9M.
  • Commonwealth Bank of Australia first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Commonwealth Bank of Australia's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $126M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Commonwealth Bank of Australia's 13F filing for Q4 2015, filed 16 Feb 2016.